双特异性T细胞衔接器tarlatamab在广泛期小细胞肺癌取得突破

    The Bispecific T-Cell Engager Tarlatamab Made a Breakthrough in Extensive Stage Small-Cell Lung Cancer

    /

    返回文章
    返回